Cancer Guide Blog: July 2008

Thursday, July 31, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Laboratory And Mouse Studies Show Targeted Drug Blocks The Growth Of Breast Cancer Cells That Spread To The Brain
http://www.medicalnewstoday.com/articles/116690.php
Using laboratory and mouse models of human breast cancer, researchers have found that a small molecule capable of targeting specific proteins on the surface of breast cancer cells can inhibit the growth of breast cancer cells that migrate to the brain.

----------------------------------------------
** CANCER / ONCOLOGY News **

Vote Now For The 2008 Beacons Of Hope Awards, Lymphoma Association, UK
http://www.medicalnewstoday.com/articles/116789.php
The Lymphoma Association, the only specialist UK charity that provides medical information and support to lymphatic cancer patients, their families and friends, is calling for nominations for their annual Beacons of Hope Awards.

Journal Of The National Cancer Institute July 29
http://www.medicalnewstoday.com/articles/116735.php
The Same Dose of Anthracycline Is Not Safe for EveryoneNot all patients can tolerate the currently recommended cumulative dose of epirubicin. New models can help physicians calculate the epirubicin dose associated with a 5 percent risk of cardiotoxicity for individual patients.

Despite Hazards, 1/5 Of British Adult Survivors Of Childhood Cancer Are Smokers
http://www.medicalnewstoday.com/articles/116731.php
One-fifth of British adult survivors of childhood cancers are current smokers, and nearly a third have been regular smokers at some point in their lives, according to a study in the July 29 online issue of the Journal of the National Cancer Institute.

Sunitinib Malate Is Active Against Human Urothelial Carcinoma And Enhances The Activity Of Cisplatin In A Preclinical Model
http://www.medicalnewstoday.com/articles/116724.php
UroToday.com - Standard front-line cisplatin-based combination chemotherapy for metastatic transitional cell carcinoma (TCC) with either MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) or GC (gemcitabine, cisplatin) yields a median survival of approximately 15 months.

Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course Of Bleomycin And Etoposide Plus Cisplatin Chemotherapy
http://www.medicalnewstoday.com/articles/116713.php
UroToday.com - In the June 20, 2008 issue of the Journal of Clinical Oncology, Dr. Peter Albers and colleagues presented the results of a large randomized German trial in men with stage I nonseminomatous germ cell tumors (NSGCT).

Seattle's Swedish Cancer Institute First In U.S. To Treat Cancer Patient With Elekta VMAT
http://www.medicalnewstoday.com/articles/116708.php
A patient with pancreatic cancer recently became the first person in the United States to receive treatment using Elekta VMAT (Volumetric intensity Modulated Arc Therapy) at Seattle's Swedish Cancer Institute.

Giving 'Meaning' To Measurement In Prostate Cancer
http://www.medicalnewstoday.com/articles/116640.php
Can scores of patient-reported outcome (PRO) measures be made more meaningful to patients and physicians? For years patients, physicians, and policy makers have questioned the usefulness of scores generated by PRO measures.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

New Data On Nymox BPH Drug To Be Presented At American Urological Association Meeting In Monterey October 26-30
http://www.medicalnewstoday.com/articles/116774.php
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that new clinical trial data concerning the safety and efficacy of the Company's NX-1207 for benign prostatic hyperplasia (BPH) will be presented at the Annual Meeting of the Western Section of the American Urological Association Meeting being held in Monterey, CA from October 26 to 30, 2008.

Oestrogen And Benign Prostatic Hyperplasia: Effects On Stromal Cell Proliferation And Local Formation From Androgen
http://www.medicalnewstoday.com/articles/116726.php
UroToday.com - Previous animal studies suggested a role for estrogens in the pathogenesis of benign prostatic hyperplasia (BPH) 1,2. Estrogens interact with two forms of estrogen receptor (ER), ERÎ± and ERÎ².

Pathologic T2 Stage Subgroups And Recurrence-Free Survival After Radical Prostatectomy
http://www.medicalnewstoday.com/articles/116722.php
UroToday.com - In the online version of Urology, Dr. James McKiernan and a group of investigators at Columbia University reported that while clinical subgroups of stage cT2 prostate cancer (CaP) have prognostic significance, pathologic subgroups of stage pT2 do not.

Performance Of Prostate Specific Antigen For Predicting Prostate Cancer Is Maintained After A Prior Negative Prostate Biopsy
http://www.medicalnewstoday.com/articles/116721.php
UroToday.com - In the August 2008 issue of the Journal of Urology, Dr. Ian Thompson and colleagues explored the performance characteristics of PSA after a previous negative prostate biopsy.

Prostate Cancer Detection Rate In Patients With Repeated Extended 21-Sample Needle Biopsy
http://www.medicalnewstoday.com/articles/116719.php
UroToday.com - In an article by a group of French investigators that appears in the online version of European Urology, they examine the issue of whether one negative extended prostate cancer (CaP) biopsy should reassure patients that they do not have CaP.

New Treatment For Advanced Prostate Cancer
http://www.medicalnewstoday.com/articles/116641.php
Researchers at the University of Adelaide have developed a novel approach to treating advanced prostate cancer that could be more effective with fewer side effects.<a href="http://www.health.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Wednesday, July 30, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

AAPM Cancer Research Highlights
http://www.medicalnewstoday.com/articles/116662.php
HALF OF ALL AMERICANS will be diagnosed at some point in their lives with cancer, the number two killer in the United States. One of the professions at the frontlines in the battle against cancer are medical physicists -- scientists who use the power and innovation of physics to study and solve the most pressing medical problems.

American Institute Of Physics, Houston Meeting Highlights: Physics And The Future Of Medicine
http://www.medicalnewstoday.com/articles/116660.php
Thousands of scientists and health professionals are meeting at the 50th meeting of the American Association of Physicists in Medicine (AAPM), the largest association of medical physicists in the world.

Patients With Colon Cancer Who Have A Family History Of Colorectal Cancer Have Lower Risk Of Recurrence And Death
http://www.medicalnewstoday.com/articles/116611.php
Patients with stage III colon cancer who have a family history of colorectal cancer in a first-degree relative have a lower risk of recurrence and death than those without, according to a major study looking at the link between inherited colorectal cancer and survival.

Amendment For ELACYT Clinical Program Following Evaluation Of All Clinical Data Available For ELACYT(TM), Both In Haematology And Solid Tumours
http://www.medicalnewstoday.com/articles/116609.php
"We are now focusing our clinical trials with ELACYT primarily on haematological cancers reflecting our recently gained in-depth knowledge of certain important cellular uptake mechanisms, whilst we continue to evaluate the clinical activity of an intense dosing regimen in ovarian cancer ", says Geir Christian Melen, CEO of Clavis Pharma.

Collaboration Is First Step Towards Collecting - And Analyzing - Data Designed To Provide Better, More Personalized Cancer Treatment
http://www.medicalnewstoday.com/articles/116569.php
The field of personalized cancer research and treatment grows with each day. And a new collaboration with Washington's largest biomedical research organization and an international research and biobanking company is contributing to that growth.

How Molecules Out Of Balance Lead To Human Multiple Myeloma And Other Cancers
http://www.medicalnewstoday.com/articles/116562.php
An international team of scientists has identified processes that are heavily implicated in human multiple myeloma and other B cell cancers, moving us closer to developing quick tests and readouts that could help in the tailored treatment of patients.

Nanoparticles + Light = Dead Tumor Cells
http://www.medicalnewstoday.com/articles/116560.php
Medical physicists at the University of Virginia have created a novel way to kill tumor cells using nanoparticles and light. The technique, devised by Wensha Yang, an instructor in radiation oncology at the University of Virginia, and colleagues Ke Sheng, Paul W.

Marinating Meats Prior To Grilling May Decrease Cancer Forming Compounds
http://www.medicalnewstoday.com/articles/116557.php
Outdoor cooking season is at its peak, and now there are even more reasons to marinade meats before grilling. New research published in the Journal of Food Science suggests that marinating meats may decrease the cancer-forming compounds called heterocyclic amines (HCA), which are produced during grilling, by over 70 percent.

Cancer Vaccine Quest Delivers New Findings
http://www.medicalnewstoday.com/articles/116555.php
On the rocky road of cancer research, Indiana State University scientists have made important discoveries.In developing vaccines for cancer and infectious diseases, researchers often trick the immune system by mixing "adjuvants" with the vaccines (proteins, killed cancer cell or infectious agents).

New Disease Fighting Nanoparticles Look Like Miniature Pastries
http://www.medicalnewstoday.com/articles/116550.php
Ultra-miniature bialy-shaped particles called nanobialys because they resemble tiny versions of the flat, onion-topped rolls popular in New York City could soon be carrying medicinal compounds through patients' bloodstreams to tumors or atherosclerotic plaques.

50th AAPM Meeting In Houston, July 27-31: Science Highlights
http://www.medicalnewstoday.com/articles/116536.php
Whether X-rays for CT scans, sound waves for ultrasound, magnetic fields for MRI, or antimatter for PET scans, the "stuff" of physics has revolutionized the practice of medicine. In the last half century, the field of medical physics has emerged thanks to the efforts of scientists who develop these technologies and bring them to the clinic.

UT Southwestern Digestive Specialists Freeze Out Esophagus Cancer With New Therapy
http://www.medicalnewstoday.com/articles/116504.php
UT Southwestern Medical Center gastroenterologists are using a new method to freeze damaged cells in the esophagus, preventing them from turning cancerous.The Food and Drug Administration-approved cryoablation therapy helps Barrett's esophagus patients with dysplasia, a condition in which normal cells are transformed into potentially cancerous ones.

Study Finds Low Survival For Pediatric Cancer In Low- And Mid-income Countries
http://www.medicalnewstoday.com/articles/116187.php
The My Child Matters program is part of the International Union AgainstCancer's (UICC) campaign and is dedicated to improving informationdissemination about cancer in children to health professionals and thegeneral public, to improve early diagnosis and access to care, and tosupport children with cancer and their families in the developingworld.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

GTx Announces Phase III Clinical Development Of Toremifene 20 Mg On Course Following Planned Safety Review
http://www.medicalnewstoday.com/articles/116540.php
GTx, Inc. (Nasdaq: GTXI), announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN).

-------------------------------------------------------------

Tuesday, July 29, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Electronic Brachytherapy Accurately Delivers Non-Radioactive Therapy Directly To Breast And Endocavitary Cancer Sites
http://www.medicalnewstoday.com/articles/116394.php
The ability of Electronic Brachytherapy to accurately and consistently deliver localized, non-radioactive radiation treatment directly to cancer sites is the focus of a symposium and multiple research papers accepted for presentation at the 50th American Association of Physicists in Medicine Meeting, July 27 - 31 in Houston.

----------------------------------------------
** CANCER / ONCOLOGY News **

New Study Shows Drug Combats Previously Untreatable Prostate Cancers
http://www.medicalnewstoday.com/articles/116491.php
New, groundbreaking research reveals a drug, discovered at The Institute of Cancer Research, could treat up to 80 per cent of patients with aggressive and previously drug resistant prostate cancer, according to a study published in the Journal of Clinical Oncology .

Clues To Preventing And Treating Cancer Spread Provided By Study
http://www.medicalnewstoday.com/articles/116466.php
Isn't it odd that cancer cells from one organ, such as the skin, can travel and take root in a totally different organ, like the lung?What's more, why is it that certain cancers prefer to spread, or metastasize, to certain places? Prostate cancer usually moves to bone; colon cancer, to the liver.

Dividing Cells And Micromanagement
http://www.medicalnewstoday.com/articles/116460.php
Micromanagers may generate resentment in an office setting, but they get results in your body. New data indicate that a dividing cell takes micromanagement to the extreme, tagging more than 14,000 different sites on its proteins with phosphate, a molecule that typically serves as a signal for a variety of biological processes.

A New Biomarker For Early Cancer Detection? Research Reveals That 'Microrna' May Fit The Bill
http://www.medicalnewstoday.com/articles/116404.php
Scientists at Fred Hutchinson Cancer Research Center have discovered that microRNAs molecular workhorses that regulate gene expression are released by cancer cells and circulate in the blood, which gives them the potential to become a new class of biomarkers to detect cancer at its earliest stages.

Ethanol Co-products Provide Means To Deliver Cancer Drugs
http://www.medicalnewstoday.com/articles/116403.php
The key to a better drug delivery method for cancer patients may be growing all across the Midwest, South Dakota State University research suggests.Assistant Professor Omathanu Perumal and his team in SDSU's Department of Pharmaceutical Sciences have been working with submicroscopic particles to deliver medications using the corn protein, zein.

Team Leads Research Into Robotic Surgery For Kidney Cancer
http://www.medicalnewstoday.com/articles/116400.php
Clinical research at NewYork-Presbyterian Hospital/Columbia University Medical Center is helping bring the advantages of robotic surgery, including reduced pain and quicker recovery, to kidney cancer patients.

U.S. FDA Clears Ge Healthcare's New Additions To PET/CT Line, Extending Ge's Leadership In Cancer Detection, Management And Research
http://www.medicalnewstoday.com/articles/116384.php
GE Healthcare announced that the U.S. Food and Drug Administration has granted clearance for the company's newest model of Positron Emission Tomography/ Computed Tomography (PET/CT) scanner. This new addition to GE's Discovery family of scanners continues GE's commitment to help enable the earlier detection and monitoring of disease with advanced molecular imaging technology, in both hardware and software.

American Chemical Society National Meeting Aug. 17-21 Offers Bounty Of News And Features
http://www.medicalnewstoday.com/articles/116376.php
Thousands of scientists from around the world will gather here August 17-21 to report new discoveries in medicine, energy, environment, food science, and other fields that involve chemistry during the 236th National Meeting & Exposition of the American Chemical Society (ACS).

Drugs Commonly Used For Erectile Dysfunction Allowed More Chemotherapy To Reach Brain Tumors In Laboratory Animal Study
http://www.medicalnewstoday.com/articles/116363.php
In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Nventa Announces Final Data From HspE7 Phase 1 Cervical Dysplasia Trial
http://www.medicalnewstoday.com/articles/116395.php
Nventa Biopharmaceuticals Corporation (TSX: NVN) announced that it has completed analysis of immunological data from all four cohorts of its Phase 1 clinical trial for HspE7, its lead product candidate.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Polyphenon Pharma Receives Orphan Drug Designation For Its Botanical Drug, Polyphenon E, For The Treatment Of CLL
http://www.medicalnewstoday.com/articles/116391.php
Polyphenon Pharma, an emerging research-based pharmaceutical company, announced that the Food and Drug Administration (FDA) has granted Orphan Drug Designation to its botanical drug, Polyphenon E(R), for the treatment of chronic lymphocytic leukemia (CLL).

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

-------------------------------------------------------------

Monday, July 28, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Breast Cancer Risk Prediction Using Hip Bone Density
http://www.medicalnewstoday.com/articles/116307.php
Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. That is the conclusion of a new study published in the September 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

----------------------------------------------
** CANCER / ONCOLOGY News **

Veterans With Asbestos-Related Breathing Diseases May Be Entitled To Compensation From The Federal Government, Canada
http://www.medicalnewstoday.com/articles/116350.php
The Lung Association recommends that navy veterans who worked on ships or shipyards during the Second World War and up until the 1970s to see their doctor for an examination. These veterans may have been exposed to asbestos and may have an asbestos-related breathing disease as a result.

Rectal Cancer Patients Benefit From Minimally Invasive Surgery
http://www.medicalnewstoday.com/articles/116318.php
A group of Houston colorectal surgeons have conducted one of the largest studies to date of the patient benefits of minimally invasive laparoscopic surgery for rectal cancer, leaving behind no markers for cancer.

$8.5M Gift Received By American Cancer Society To Finance Thyroid Cancer Research
http://www.medicalnewstoday.com/articles/116281.php
The American Cancer Society, the nation's largest voluntary health organization, has received a gift of $8.5 million from a single anonymous donor. The contribution, one of the largest individual scientific research gifts in the Society's 95-year history, will be earmarked for targeted investigation into a genetic disorder that leads to a high lifetime risk of several types of cancer, most often thyroid cancer.

New York Times Examines Congressional Black Caucus' Position On Tobacco Regulation Bill
http://www.medicalnewstoday.com/articles/116273.php
The <a href="http://www.nytimes.com/2008/07/25/business/25menthol.html" target="_new"><cite>New York Times</cite></a> on Friday examined how a "rift has opened in the 43-member" <a href="http://www.

Presumptive Republican Presidential Nominee McCain Discusses Cancer Issues At Ohio Event
http://www.medicalnewstoday.com/articles/116262.php
Presumptive Republican presidential nominee Sen. <a href="http://www.health08.org/candidates/mccain.cfm" target="_new">John McCain</a> (Ariz.) on Thursday discussed issues related to cancer at a town hall meeting in Columbus, Ohio, hosted by cyclist and testicular cancer survivor Lance Armstrong, the <a href="http://www.

Plasma DNA Level Is A Reliable Marker Of Recurrent Esophageal Cancer, Study Finds
http://www.medicalnewstoday.com/articles/116246.php
New research published in the July issue of the Journal of the American College of Surgeons shows elevated plasma DNA is a reliable marker of recurrent esophageal cancer. The study also suggests that plasma DNA levels rise before clinical evidence of cancer recurrence in the majority of patients.

England And Wales Lead Reduction In Cancer Deaths And Increase In Cancer Spend
http://www.medicalnewstoday.com/articles/116089.php
A comprehensive analysis, published in the online journal ecancermedicalscience, has detailed how cancer death rates in developed countries have fallen substantially in the last 20 years, despite a general increase in the prevalence of cancer.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Cognitive Effects May Be Experienced By Prostate Cancer Patients Undergoing Hormone Therapy
http://www.medicalnewstoday.com/articles/116305.php
A recent review of the literature has found that hormone deprivation therapy, a commonly used treatment for prostate cancer, may have subtle adverse effects on cognition in patients--such as in the ability to recall and concentrate.

Marketing Authorization Application For Satraplatin Is To Be Withdrawn
http://www.medicalnewstoday.com/articles/116301.php
GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) reported that the Company has been informed by its partner for satraplatin in Europe that they plan to withdraw the Marketing Authorization Application (MAA) for satraplatin plus prednisone for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.

Key Prostate Motion Management Experience Using The Calypso® Medical's 4D Localization System To Be Presented At The 50th AAPM Annual Meeting
http://www.medicalnewstoday.com/articles/116296.php
Calypso Medical Technologies, Inc. (Calypso Medical) has announced that eight new abstracts will be presented on prostate motion management in radiation therapy using the Calypso® 4D Localization System (Calypso System) at the AAPM annual scientific meeting July 27-31, 2008 in Houston, Texas.

Strategic Plan For Research Into Benign Prostate Disease Published By NIDDK
http://www.medicalnewstoday.com/articles/116282.php
For the first time, a strategic plan for research into benign prostate disease, based on the latest scientific knowledge, has been published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).

-------------------------------------------------------------

Sunday, July 27, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Cancer Treatment Application Of The Aethlon Hemopurifier® Published In Journal Of Translational Medicine
http://www.medicalnewstoday.com/articles/116229.php
Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that a peer reviewed scientific paper coauthored by Aethlon researchers has been published in the Journal of Translational Medicine. The paper entitled, "Exosomes as a Tumor Immune Escape Mechanism: Possible Therapeutic Implications" discusses the mechanism by which exosomes released by cancerous tumors are able to kill off immune cells in cancer patients.

Cornerstone Pharmaceuticals Announces Approval To Conduct Phase I/II Clinical Trial Of CPI-613 In Cancer Patients By US FDA
http://www.medicalnewstoday.com/articles/116207.php
Cornerstone Pharmaceuticals, Inc., a privately held pharmaceutical company, announced today that it has received clearance from the US Food and Drug Administration (FDA) to begin a Phase I/II clinical trial evaluating the safety and early efficacy of its first-in-class Altered Energy Metabolism-Directed (AEMD) compound, CPI-613, in a variety of cancer types.

Ceplene® Receives Positive European Opinion For Approval From CHMP - Acute Myeloid Leukemia
http://www.medicalnewstoday.com/articles/116199.php
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion regarding the marketing authorization for Ceplene® (histamine dihydrochloride), for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

Launch Of New Interactive Non-Small Cell Lung Cancer Resource For Physicians
http://www.medicalnewstoday.com/articles/116241.php
EPG Health Media, developers of e-communication and clinical information solutions for the health sector, today announced the launch of a new interactive Non-small Cell Lung Cancer Knowledge Centre within the web-based physician resource <a href="http://www.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Saturday, July 26, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Nexavar Study Demonstrates Significant Improvement In Overall Survival In Patients With Liver Cancer
http://www.medicalnewstoday.com/articles/116223.php
Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that The New England Journal of Medicine published landmark results of a Nexavar study in liver cancer. The data of the Phase III trial showed that Nexavar® (sorafenib) tablets decreased the absolute risk of death by 31 percent in patients with unresectable hepatocellular carcinoma (HCC), or liver cancer, versus patients who received placebo.

Researchers Use New Tools To Combat Skin Cancer
http://www.medicalnewstoday.com/articles/116213.php
There's something new under the sun at South Dakota State University: Researchers are working with molecules that protect against skin cancer and may even help undo the sun's damage.Distinguished professor Chandradhar Dwivedi, head of the Pharmaceutical Sciences Department in the College of Pharmacy at SDSU, said the work could be commercialized within 10 years.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Journal Of Clinical Oncology Article Highlights CellSearch™ Circulating Tumor Cell Test In Treatment Of Metastatic Colorectal Cancer
http://www.medicalnewstoday.com/articles/116220.php
An international, prospective clinical trial found the number of circulating tumor cells (CTCs) is a strong indicator of progression-free and overall survival among metastatic colorectal cancer patients, according to a report published in the July 1 issue of the Journal of Clinical Oncology.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Friday, July 25, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Identification Of New Cellular Pathway Linked To Cancer May Enable Cells To Be Sensitized To Chemotherapy
http://www.medicalnewstoday.com/articles/116167.php
In the life of a cell, the response to DNA damage determines whether the cell is fated to pause and repair itself, commit suicide, or grow uncontrollably, a route leading to cancer. In a new study, published in the July 25th issue of Cell, scientists at NYU Langone Medical Center have identified a way that cells respond to DNA damage through a process that targets proteins for disposal.

Novel Structure Proteins Could Play A Role In Apoptosis
http://www.medicalnewstoday.com/articles/116165.php
Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death.

Novel Structure Protiens Could Play A Role In Apoptosis
http://www.medicalnewstoday.com/articles/116110.php
Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death.

Soma Intimates Joins The Battle Against Ovarian Cancer
http://www.medicalnewstoday.com/articles/116094.php
Soma Intimates is passionate about helping women look and feel their best. On Saturday, July 26th Soma Intimates is scheduled to appear during the QVC Presents Super Saturday Live broadcast beginning at 2 PM (ET).

American Society For Therapeutic Radiology And Oncology Strengthens Government Relations Department
http://www.medicalnewstoday.com/articles/116081.php
The American Society for Therapeutic Radiology and Oncology (ASTRO) has promoted two members of its Government Relations Department staff in recognition of their outstanding work to promote legislative policies that benefit the field of radiation oncology.

NEJM Publishes Nexavar® (sorafenib) Study Demonstrating Major Improvement In Overall Survival In Patients With Advanced Hepatocellular Carcinoma
http://www.medicalnewstoday.com/articles/116053.php
The New England Journal of Medicine (NEJM) has today published the results of the Sorafenib HCC Assessment Randomized Protocol (SHARP) Phase 3 trial in which Nexavar® (sorafenib) tablets demonstrated that "survival rates at 1 year were 44% in the sorafenib group and 33% in the placebo group.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

CDC, FDA Release Statement Saying HPV Vaccine Gardasil Remains Safe, Effective
http://www.medicalnewstoday.com/articles/116138.php
 Officials from CDC and FDA on Tuesday released a statement that says a review of available information by the two agencies has found that Merck's human papillomavirus vaccine Gardasil "continues to be safe and effective" for protecting women and girls from a virus that causes cervical cancer, and that its "benefits continue to outweigh its risks," <A href="http://www.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Shortage Of Cancer Drugs Impacts Iraqi Children With Leukemia
http://www.medicalnewstoday.com/articles/116114.php
A study led by Vanderbilt-Ingram Cancer Center researchers revealed that some Iraqi children diagnosed with leukemia paid a steep price for economic sanctions imposed by the United Nations against the Iraqi government.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Thursday, July 24, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Increase In Breast Cancer Among Alaska Native Women Appears To Be Slowing, Researchers Say
http://www.medicalnewstoday.com/articles/116036.php
The 30-year increase in breast cancer rates among Alaska Native women appears to be leveling off, according to researchers making a presentation on Tuesday at a cancer symposium in Anchorage, Alaska, the <a href="http://www.

News From The American Society Of Plastic Surgeons August 2008
http://www.medicalnewstoday.com/articles/116008.php
Is Breast Reduction More Dangerous for Morbidly Obese Women?As the obese population increases, more overweight women are consulting plastic surgeons for breast reductions. In previous studies, this group of patients had been thought to have higher complication rates.

Alternative To Mammograms Under Study
http://www.medicalnewstoday.com/articles/115915.php
Whether a painless, portable device that uses electrical current rather than X-ray to look for breast cancer could be an alternative to traditional mammograms is under study at the Medical College of Georgia.

----------------------------------------------
** CANCER / ONCOLOGY News **

Cancer Institute Urges Caution With Cell Phones
http://www.medicalnewstoday.com/articles/116000.php
A prominent US cancer institute has posted a notice on its website urging cell phone users to take precautions when using cell phones because advice from an international panel of experts says cell phones have not been around long enough for scientists to be sure about their safety.

Comparison Of Postoperative Pain, Convalescence, And Patient Satisfaction Between Laparoscopic And Percutaneous Ablation Of Small Renal Masses
http://www.medicalnewstoday.com/articles/115986.php
UroToday.com - In this study of 58 laparoscopic cryoablations, 20 percutaneous cryoablations, and 15 percutaneous radiofrequency ablations for renal tumors averaging 2.2-2.6 cm., the percutaneous approaches resulted in statistically significant differences: shorter anesthesia time, shorter hospital stay, earlier return to no strenuous activity, and shorter time to full recovery.

Wilms' Tumor Associated With Vertebral Anomalies
http://www.medicalnewstoday.com/articles/115985.php
UroToday.com - Dr. Serhan Kupeli, and his colleagues presented a case of a child who was diagnosed with Wilms' tumor. The child was given a thorough evaluation for tumor extension and was found to have several vertebral abnormalities.

Familial And Genetic Risk Of Transitional Cell Carcinoma Of The Urinary Tract
http://www.medicalnewstoday.com/articles/115981.php
UroToday.com - Bladder cancer is the second most common genitourinary malignancy, and the incidence has continued to rise modestly since 1975. It occurs primarily in middle-aged men, and the majority of newly-diagnosed bladder cancers are low-grade, superficial, transitional cell carcinomas (TCCs).

Advanced Liver Cancer Patients Live Longer By Taking Anti Cancer Drug Sorafenib
http://www.medicalnewstoday.com/articles/115975.php
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug.

Sound Pharmaceuticals Files Second IND With The FDA For The Prevention Of Chemotherapy Induced Hearing Loss In Advanced Stage Cancer
http://www.medicalnewstoday.com/articles/115961.php
Sound Pharmaceuticals (SPI) has filed an Investigational New Drug Application with the FDA for the clinical testing of a proprietary formulation of ebselen for the prevention of chemotherapy induced hearing loss or ototoxicity.

VEGFbTM Has Been Granted Orphan Drug Designation By The FDA For The Treatment Of Advanced Melanoma
http://www.medicalnewstoday.com/articles/115955.php
PhiloGene, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to VEGFb for the treatment of patients with advanced melanoma. This approval is for a larger subset of melanoma patients than was requested, and includes melanoma in stages IIb through IV.

Tumor Growth Significantly Inhibited When Tumor Blood Flow Is Interrupted Following Radiotherapy
http://www.medicalnewstoday.com/articles/115940.php
Vascular disrupting agents (VDA) are a new class of anti-cancer drugs which obliterate all vessels in tumors and prevent nutrient supply to the tumor, thereby leading to necrosis of solid tumors.

Immunotherapy With Leukemia-cell-derived Heat Shock Protein 70 Triggers Induction Of Leukemia-specific Antibodies
http://www.medicalnewstoday.com/articles/115938.php
Even after chemotherapies and stem cell transplants, relapses still occur in leukemia patients. This study established a mouse model after bone marrow transplant and found that the immunization of mice with leukemia-cell-derived heat shock protein 70 (HSP) induced leukemia-specific immunities and prolonged their survival.

Individual Tumorigenesis Pathways Of Sporadic Colorectal Adenocarcinomas Linked To The Biological Behaviors Of Tumors
http://www.medicalnewstoday.com/articles/115937.php
Particular pathways of colorectal tumor growth are closely associated with characteristic pathologic features which, in turn, determine biological behaviors such as tumor growth, invasion and recurrence.

Roswell Park Surgeons Perform 100th Bladder Cancer Robotic Surgery
http://www.medicalnewstoday.com/articles/115920.php
The Minimally Invasive Surgical Center at Roswell Park Cancer Institute (RPCI) has performed its 100th robot-assisted radical cystectomy for advanced bladder cancer using the da Vinci® Surgical Robotic System which distinguishes RPCI as one of the world's premier academic institutions for the procedure.

Cancer Patient Survival Linked To The Checking Of More Lymph Nodes
http://www.medicalnewstoday.com/articles/115913.php
Why do patients with gastric or pancreatic cancer live longer when they are treated at cancer centers or high-volume hospitals than patients treated at low-volume or community hospitals?New research from Northwestern University's Feinberg School of Medicine found that cancer patients have more lymph nodes examined for the spread of their disease if they are treated at hospitals performing more cancer surgeries or those designated as comprehensive cancer centers.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

University Of Iowa To Begin Using LUMA(R) Cervical Pre Cancer Imaging Device
http://www.medicalnewstoday.com/articles/115968.php
SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego-based medical devices company, announced that it has placed its LUMA Cervical Imaging System to detect pre-cancers at the University of Iowa in Iowa City, Iowa under the direction of Dr.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

Gates And Bloomberg Unite In Global Fight Against Tobacco
http://www.medicalnewstoday.com/articles/116039.php
Two of the world's richest philanthropists, Bill Gates and Michael Bloomberg pledged on Wednesday to spend 500 million dollars to make people all over the world stop smoking. They announced the news together at a press conference at the TheTimesCenter in Midtown Manhattan.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Transurethral Resection Of The Prostate Role In Patients With Elevated PSA Level, Minor Lower Urinary Tract Symptoms, And Bladder Outlet Obstruction
http://www.medicalnewstoday.com/articles/115983.php
UroToday.com - In the online edition of European Urology, Dr. Koenraad van Renterghem and associates presented their data on how to manage patients with an elevated PSA and proven bladder outlet obstruction.

Partial Salvage Cryoablation Of The Prostate For Recurrent Prostate Cancer After Radiotherapy Failure
http://www.medicalnewstoday.com/articles/115982.php
UroToday.com - In the online edition of Urology, Drs. Michael Eisenberg and Katsuto Shinohara reported on their experience using partial (unilobar) cryotherapy for patients with a local recurrence of prostate cancer (CaP) following radiotherapy (XRT).

Dendreon Expects Interim Data Analysis For Phase 3 PROVENGE IMPACT Trial In October
http://www.medicalnewstoday.com/articles/115966.php
Dendreon Corporation (Nasdaq: DNDN) announced that it expects the Independent Data Monitoring Committee (IDMC) to review in October 2008 the interim analysis of overall survival relating to the Company's Phase 3 IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment, also known as D9902B) clinical trial of PROVENGE(R) (sipuleucel-T).

-------------------------------------------------------------

Wednesday, July 23, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Mammogram Pain Reduced By Over-The-Counter Anesthetic Gel
http://www.medicalnewstoday.com/articles/115792.php
The simple application of a pain-relieving gel may reduce the breast discomfort some women experience during mammography exams, according to the results of a clinical trial published in the online edition of Radiology.

----------------------------------------------
** CANCER / ONCOLOGY News **

Merck Serono Receives European Approval For Broader Usage Of Erbitux In Metastatic Colorectal Cancer Including 1st-Line Treatment
http://www.medicalnewstoday.com/articles/115942.php
Merck KGaA announced today that it has been granted approval by the European Commission for Erbitux® (cetuximab), to update its license for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type mCRC (metastatic colorectal cancer) in combination with chemotherapy, and as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecan.

St. Louis Post-Dispatch Examines Treatment Options For Pregnant Women With Cancer
http://www.medicalnewstoday.com/articles/115882.php
 The <A href="http://www.stltoday.com/stltoday/news/stories.nsf/news/sciencemedicine/story/d04a9312054ddb608625748c000e2a7b?OpenDocument" target=_new><CITE>St. Louis Post-Dispatch</CITE></A> on Sunday examined the "life-and-death" decisions pregnant women with cancer must make and the treatment options available to them.

Cancer Drug Delivery Research At Case Western Reserve University Cuts Time From Days To Hours
http://www.medicalnewstoday.com/articles/115876.php
Researchers at Case Western Reserve University have developed a technique that has the potential to deliver cancer-fighting drugs to diseased areas within hours, as opposed to the two days it currently takes for existing delivery systems.

End Of Life Physician-Patient Communication: Ensuring Final Chapter Is Enacted With The Greatest Skill And Compassion Possible
http://www.medicalnewstoday.com/articles/115855.php
Although a growing body of research supports a link between effective communication and patient, family and physician satisfaction, doctors, including oncologists and other specialists who frequently care for terminal patients, do not routinely receive training in end-of-life conversations during medical school, residency training, or after they start to practice medicine.

First Cancer Diagnostic Test Based On Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
http://www.medicalnewstoday.com/articles/115853.php
Rosetta Genomics, Ltd. (NASDQ: ROSG) announces that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.

Providing Worldwide Customers With A Single Source Solution For Cancer Treatment Rooms
http://www.medicalnewstoday.com/articles/115846.php
Veritas Medical Solutions, LLC has been formed to provide worldwide customers with a single source solution for cancer treatment rooms. Focused on providing innovative modular designs, products and services, the company provides all the pieces necessary for a rapid, turnkey therapy room installation.

MIMA Cancer Center First In World To Treat Soft Tissue Carcinoma With Stereotactic Body Radiotherapy Using RapidArc™ Radiotherapy Technology
http://www.medicalnewstoday.com/articles/115845.php
Doctors at Melbourne Internal Medical Associates (MIMA) Cancer Center have become the first in Florida to treat cancer using RapidArc™ radiotherapy technology from Varian Medical Systems (NYSE: VAR).

Cancer Molecular Diagnostics: On The Critical Path To Personalized Medicine
http://www.medicalnewstoday.com/articles/115820.php
The Healthcare practice at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the North American cancer molecular diagnostics market to be held on Thursday July 24, 2008 at 10:00 a.

Hospitals Vary In Number Of Lymph Nodes Examined In Patients With Gastric And Pancreatic Cancer
http://www.medicalnewstoday.com/articles/115814.php
Researchers have found differences in hospitals giving care to patientswith gastric or pancreatic cancer. The report, published in the Julyissue of Archives of Surgery, found that ifpatients are treated at hospitals that conduct relatively more cancersurgeries or at hospitals deemed comprehensive care centers, thepatients have more lymph nodes examined by physicians who areinvestigating the spread and prognosis of their disease.

Plants Make Vaccine For Treating Type Of Cancer, Stanford Study
http://www.medicalnewstoday.com/articles/115806.php
Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine.

Research Identifies Best Way To Discover If Cancer Has Spread
http://www.medicalnewstoday.com/articles/115801.php
For patients with head and neck cancer, accurately determining how advanced the cancer is and detecting secondary cancers usually means undergoing numerous tests - until now. New Saint Louis University research has found that the PET-CT scanner can be used as a stand-alone tool to detect secondary cancers, which occur in 5 to 10 percent of head and neck cancer patients.

Unnecessary Biopsies Reduced By Team Work, SLU Researchers Find
http://www.medicalnewstoday.com/articles/115800.php
Unnecessary biopsies could be a thing of the past for patients undergoing treatment for head and neck cancer. New Saint Louis University research found that when nuclear medicine clinicians and treating physicians work together to interpret PET-CT scan results, the accuracy dramatically improves, sparring patients unnecessary pain and suffering.

NICE Drug Reviews Terminated When Manufacturers Fail To Submit Evidence, July 2008, UK
http://www.medicalnewstoday.com/articles/115777.php
Because insufficient evidence was provided by the manufacturers, NICE is unable to recommend the use the following treatments in the NHS: -- bevacizumab in combination with paclitaxel for the first-line treatment of metastatic breast cancer-- bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with inoperable advanced, metastatic or recurrent non-small-cell lung cancer (other than predominantly squamous cell histology) -- carmustine implants as an adjunct to surgery in patients with recurrent glioblastoma multiforme (a type of brain cancer) for whom surgery is appropriate-- cetuximab for the treatment of colorectal cancer following failure of oxaliplatin-containing chemotherapyAndrew Dillon, NICE Chief Executive said: "NICE is committed to producing timely guidance to the NHS using our fast-track single technology appraisal process.

Intervention Delivered By Nurses Can Help Combat Depression In Cancer Patients
http://www.medicalnewstoday.com/articles/115759.php
A team of Scottish researchers have shown that cancer patients offered a depression care intervention - delivered by specially trained oncology nurses with no previous psychiatric experience - showed improvements in symptoms of depression compared to patients offered usual care.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

CTI To Meet With The FDA To Discuss Filing Of A Supplemental Biologics License Application For Zevalin(R)
http://www.medicalnewstoday.com/articles/115863.php
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that the Company has scheduled a meeting with the U.S. Food and Drug Administration (FDA) in September to discuss the possibility of filing a supplemental Biologics License Application (sBLA) for use of Zevalin(R) ([90Y]-ibritumomab tiuxetan) as consolidation therapy after remission induction in previously untreated patients with follicular non-Hodgkin's lymphoma.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Visualisation Software To Aid Prostate Cancer Detection
http://www.medicalnewstoday.com/articles/115872.php
Visualisation specialists See3D, a spin off company of the University of Aberystwyth, is developing unique, sophisticated computer-generated models that will help doctors to improve the diagnosis and treatment of prostate cancer.

Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme In Prostate Cancer Models
http://www.medicalnewstoday.com/articles/115854.php
Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, announced the presentation of positive pre-clinical animal efficacy data for its pegylated-rHuPH20 enzyme (PEGPH20) at the American Association for Cancer Research (AACR) Translational Cancer Medicine meeting in Monterey, CA.

-------------------------------------------------------------

Tuesday, July 22, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

New Central Resource For Breast Healthcare Teams Now Available
http://www.medicalnewstoday.com/articles/115796.php
The American Society of Breast Disease announces the opening of a career center to link breast healthcare professionals across all specialties with employers and educational opportunities. The new feature at the Society's web site at <a href="http://www.

Reduced Dose Anthracycline Pre Breast Cancer Surgery Has No Effect On Outcome
http://www.medicalnewstoday.com/articles/115712.php
Canadian researchers have discovered that there is a low risk of adverse effect from reducing pre-op chemo by up to 25%, according to findings published in the online journal ecancermedicalscience.

----------------------------------------------
** CANCER / ONCOLOGY News **

Imaging System Offers Glimpse Of Rare Mutant Cells, May Help Understand Origins Of Cancer
http://www.medicalnewstoday.com/articles/115762.php
MIT biological engineers have developed a new imaging system that allows them to see cells that have undergone a specific mutation.The work, which could help scientists understand how precancerous mutations arise, marks the first time researchers have been able to pinpoint the number and location of mutant cells - cells with a particular mutation - in intact tissue.

New Cancer Therapies And Pond Scum
http://www.medicalnewstoday.com/articles/115722.php
Researchers at the University of Illinois at Chicago College of Pharmacy are collaborating with the Ohio State University and two other organizations to discover new cancer therapies derived from natural sources such as pond scum and plants from tropical rainforests.

Rexahn Pharmaceuticals Receives U.S. Patent For New Cancer Compounds
http://www.medicalnewstoday.com/articles/115714.php
Rexahn Pharmaceuticals, Inc. (AMEX:RNN), a, leader in innovative therapeutics for life-threatening and life-debilitating diseases, today announced that the U.S. Patent & Trademark Office has issued to the Company U.

Researchers Study Causes Of Malignancy
http://www.medicalnewstoday.com/articles/115702.php
The South is known for many things hot, steamy summers, iced tea laced with sugar and friendly people with a tendency to welcome strangers. But beneath the veneer of Southern hospitality and gracious living lurks a silent killer cancer.

Once Suspect Protein Found To Promote DNA Repair, Prevent Cancer
http://www.medicalnewstoday.com/articles/115698.php
An abundant chromosomal protein that binds to damaged DNA prevents cancer development by enhancing DNA repair, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Proceedings of the National Academy of Sciences.

Precancerous Esophagus Disease Eliminated In 98.4% Of Patients Treated With HALO Ablation System
http://www.medicalnewstoday.com/articles/115697.php
BARRX Medical, Inc. announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus were free of the disease 2.5 years after non-surgical, endoscopic treatment with the HALO ablation system.

NT Radiation Oncology Moves One Step Closer, Australia
http://www.medicalnewstoday.com/articles/115657.php
The Australian and Northern Territory Governments have reached another key milestone in the development of the Radiation Oncology Unit (ROU) with the announcement of Royal Adelaide Hospital as the preferred provider.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

GeneNews Launches World's First Blood Test For Colorectal Cancer Screening
http://www.medicalnewstoday.com/articles/115696.php
GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, announced the launch of ColonSentry(TM), the world's first blood-based molecular test for colorectal cancer screening.

----------------------------------------------
** LUNG CANCER News **

Gene Panel Predicts Lung Cancer Survival
http://www.medicalnewstoday.com/articles/115701.php
Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Tobacco Used To Make Cancer Vaccine
http://www.medicalnewstoday.com/articles/115826.php
In an ironic twist to the relationship between tobacco and human health, it would seem that the future of the plant may lie in growing vaccines against cancer. Researchers in the US took antibodies from patients with a type of lymphoma, grew them in tobacco plants, extracted them, and reinjected the individualized vaccines back into the patients, where in most cases it produced an immune response that helped to fight the cancer.

Tobacco Plant Used To Make Vaccine For Treating Cancer
http://www.medicalnewstoday.com/articles/115761.php
Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Prostate Cancer Drug Breakthrough For Aggressive Form Of Disease
http://www.medicalnewstoday.com/articles/115721.php
A new trial drug called abiraterone has shown a high success rate at treating men with an aggressive, drug resistant, and often fatal form of prostate cancer. 70 to 80 per cent of the men on the trial experienced dramatic reductions in PSA (a protein marker for prostate cancer) and tumour shrinkage, even in tumours that had spread to bone and other tissue.

New Gene Combination May Cause Deadly Prostate Cancer
http://www.medicalnewstoday.com/articles/115678.php
Scientists at The Institute of Cancer Research have found that the partnering of two genes could be responsible for up to 600 British men developing a drug resistant and potentially deadly form of prostate cancer each year.

-------------------------------------------------------------

Monday, July 21, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Biocon And Abraxis BioScience Launch ABRAXANE In India For Treatment Of Breast Cancer
http://www.medicalnewstoday.com/articles/115633.php
Biocon Limited, India's pioneering biotechnology company, and Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, announced the launch of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in India for the treatment of breast cancer after failure of combination therapy for metastatic disease or relapse within six months of adjuvant chemotherapy.

----------------------------------------------
** CANCER / ONCOLOGY News **

Introgen To Present ADVEXIN Phase 3 Study Results At American Association For Cancer Research's Cancer Clinical Trials
http://www.medicalnewstoday.com/articles/115637.php
Introgen Therapeutics, Inc. (NASDAQ:INGN), a developer of targeted molecular therapies for cancer, announced that the company will present the results from its recently completed Phase 3 trial of ADVEXIN in recurrent head and neck cancer at the American Association for Cancer Research (AACR) Centennial Conference on Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine.

Stanford Study Of Dark-skinned Mice Leads To Protein Linked To Bone Marrow Failure In Humans
http://www.medicalnewstoday.com/articles/115631.php
The study of dark-skinned mice has led to a surprising finding about a common protein involved in tumor suppression, report researchers at the Stanford University School of Medicine. The results may lead to new treatments for bone marrow failure in humans.

Enzyme Expression Levels Correlated With Chemotherapy Drug Response
http://www.medicalnewstoday.com/articles/115615.php
A method that could be applied widely to explore genetic basis of cancer drug resistanceWhy do cancer patients develop resistance to chemotherapy drugs, sometimes abruptly, after a period in which the drugs seem to be working well to reduce tumors or hold them in check? Although largely a mystery to scientists, the result when this occurs is all too familiar: patients relapse and in many cases die when their cancers become resistant.

Engage GPs For More Effective Cancer Care, Medical Journal Of Australia
http://www.medicalnewstoday.com/articles/115605.php
As cancer treatment improves and more people with cancer survive, general practitioners must become more involved in all stages of the cancer journey, according to an editorial by experts in general practice in the latest issue of the Medical Journal of Australia.

Pitt University To Host Annual Pancreatic Research Meeting
http://www.medicalnewstoday.com/articles/115596.php
More than 100 physicians and scientists from around the country will discuss the latest findings in pancreatic research at PancreasFest 2008 at the Hillman Cancer Center July 24 through 26. Topics to be covered at the event will include the challenges of determining whom to screen for pancreatic cancer, new therapeutic approaches for treating pancreatic cancer, how to manage complications after pancreas surgery, and the current status and utility of biomarkers.

UC San Diego Launches Institute Of Engineering In Medicine To Accelerate Health Care Tech
http://www.medicalnewstoday.com/articles/115584.php
The world's top engineers, physicians and scientists are joining forces to conceptualize, develop and bring to reality the future tools and treatments of 21st century health care through UC San Diego's new Institute of Engineering in Medicine.

Lawmakers Address Various Health Care Topics In Opinion Pieces In The Hill
http://www.medicalnewstoday.com/articles/115572.php
<cite>The Hill</cite> on Wednesday published opinion pieces by lawmakers and federal officials discussing health care policy. Summaries appear below. <ul><li class="AdvisoryBullet">Rep. Lois Capps (D-Calif.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Sunday, July 20, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

New Approach To Studying Cancer
http://www.medicalnewstoday.com/articles/115522.php
Scientists at a Duke University medical school in Singapore have found a new way to study cancer that could be very useful for developing targeted therapies against cancer and possibly many other diseases.

Cancer Researchers Call For Ethnicity To Be Taken Into Account
http://www.medicalnewstoday.com/articles/115498.php
Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, according to a new Comment piece in The Lancet (18 July) by researchers from Imperial College London.

American Society For Microbiology Honors Rosenberg, Baselsk, De Lorenzo And Clapham
http://www.medicalnewstoday.com/articles/115344.php
American Society for Microbiology honors Steven A. RosenbergThe 2008 American Society for Microbiology (ASM) Abbott Laboratories Award in Clinical and Diagnostic Immunology was presented to Steven A.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Merck Responds To Questions About Adverse Events Reported Following Vaccination With GARDASIL®
http://www.medicalnewstoday.com/articles/115548.php
Merck issued the following statement to address questions about adverse events reported in people who had received GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant].

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Amgen Announces Positive Top-Line Results For Denosumab Treatment Of Bone Loss In Men With Non-Metastatic Prostate Cancer
http://www.medicalnewstoday.com/articles/115550.php
Amgen (NASDAQ:AMGN) announced findings from a three-year pivotal Phase 3 placebo-controlled trial evaluating denosumab in the treatment of bone loss in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer.

-------------------------------------------------------------

Saturday, July 19, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

New Computer, Most Powerful At Johns Hopkins, Will Speed Disease Research
http://www.medicalnewstoday.com/articles/115354.php
A federal grant will allow Johns Hopkins researchers to purchase a powerful $2 million computer that will speed up their efforts to find new ways to diagnose and treat brain disease, heart illnesses, cancer and other medical ailments.

----------------------------------------------
** CANCER / ONCOLOGY News **

USP Chief Science Officer Darrell Abernethy To Receive ACCP Distinguished Service Award
http://www.medicalnewstoday.com/articles/115467.php
The U.S. Pharmacopeial (USP) Convention is pleased to announce that its chief science officer, Darrell Abernethy, M.D., Ph.D., will be honored with the American College of Clinical Pharmacology's (ACCP) Nathaniel T.

$10.9M NCI Grant For Studies Of Virus Cancer Models
http://www.medicalnewstoday.com/articles/115465.php
A team of researchers from Ohio State University's Comprehensive Cancer Center (OSUCCC) and the University's College of Veterinary Medicine have received a $10.9 million, five-year grant from the National Cancer Institute (NCI) to further their studies of retrovirus-associated cancer.

Comprehensive Clinic For Gastrointestinal Cancers Opens At Rush University Medical Center, USA
http://www.medicalnewstoday.com/articles/115286.php
Patients benefit from a team approach at the new Coleman Foundation Comprehensive Clinic for Gastrointestinal Cancers at Rush University Medical Center. Experts in gastroenterology, medical oncology, surgery, radiation oncology, pathology and psychosocial oncology as well as nutrition and genetics come together to meet with new patients and develop a defined treatment plan.

Bladder-Sparing Therapy For Muscle-Infiltrating Bladder Cancer
http://www.medicalnewstoday.com/articles/115280.php
UroToday.com - Muscle infiltrating bladder cancer is a life-threatening disease. Despite diagnostic and surgical advancements in the last decade, after cystectomy 5-year disease recurrence rate is 30-40% even in referral centers.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

The HFSP Journal Publishes New Article On The Impact Of Mechanical Stimulation On The Initiation Of Colon Cancer
http://www.medicalnewstoday.com/articles/115543.php
The HFSP Journal, the new interdisciplinary journal for scientists conducting high quality, innovative research at the interface between biology and the physical sciences is pleased to announce that the latest article on the impact of mechanical stimulation on the initiation of colon cancer in now available online at <a href="http://hfspj.

ERBITUX® (Cetuximab) Receives Approval In Japan For Use In Advanced Colorectal Cancer
http://www.medicalnewstoday.com/articles/115506.php
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that ERBITUX® (cetuximab) has received marketing authorization in Japan for use in treating patients with advanced or metastatic colorectal cancer (mCRC).

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Impact Of Surgical Volume On The Rate Of Lymph Node Metastases In Patients Undergoing Radical Prostatectomy
http://www.medicalnewstoday.com/articles/115285.php
UroToday.com - In this online publication by Dr. Alberto Briganti and associates that appears in European Urology, the authors hypothesized that surgical volume (SV) is related to the detection rate of lymph node invasion (LNI) in a single-institution cohort of men treated with radical prostatectomy (RP) and extended pelvic lymph node dissection (ePLND).

Association Between Serum Prostate-Specific Antigen Level, Liver Function Tests And Lipid Profile In Healthy Men
http://www.medicalnewstoday.com/articles/115283.php
UroToday.com - In the online version of the BJU International, a group of Korean investigators has reported on the impact of liver function and lipid parameters on PSA levels. The liver is involved in eliminating serum PSA, but the kidneys and lungs are not.

-------------------------------------------------------------

Friday, July 18, 2008

Medical News Today News Alert

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Light Shed On Ways Circadian Disruption Affects Human Health
http://www.medicalnewstoday.com/articles/115370.php
Growing evidence indicates that exposure to irregular patterns of light and darkness can cause the human circadian system to fall out of synchrony with the 24-hour solar day, negatively affecting human health - but scientists have been unable to effectively study the relationship between circadian disruptions and human maladies.

Study Of 31 Countries Finds Wide Variations In Cancer Survival Rates
http://www.medicalnewstoday.com/articles/115086.php
A large study published in The Lancet Oncology has found that there are wide variations in cancer survival rates between and within many countries around the world. Professor Michel Coleman (Cancer Research UK Cancer Survival Group and London School of Hygiene and Tropical Medicine) and over 100 colleagues working on the CONCORD study analyzed 31 countries that provided data on cancer survival.

----------------------------------------------
** CANCER / ONCOLOGY News **

Researchers Find Better Way To Identify Melanoma
http://www.medicalnewstoday.com/articles/115493.php
University of Rochester Medical Center researchers found a new protein produced excessively in malignant melanoma, a discovery that is particularly relevant as skin cancer rates climb dramatically among young women.

Bradmer Reports Progression Free Survival Data From Previous Phase II Glioblastoma Multiforme Trials
http://www.medicalnewstoday.com/articles/115419.php
Bradmer Pharmaceuticals Inc. (TSX: BMR), a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, released progression free survival (PFS) data from two previously conducted Phase II trials of Neuradiab(TM) in glioblastoma multiforme (GBM) patients.

New Research From Rhode Island Hospital May Help Predict Outcomes For Stomach Cancer Patients
http://www.medicalnewstoday.com/articles/115374.php
Researchers at Rhode Island Hospital have identified two potential molecular markers that may predict outcomes for patients with stomach cancer, one of the most common and fatal cancers worldwide.

Researchers Target Specific Genes, Reduce Cancer Cells
http://www.medicalnewstoday.com/articles/115255.php
A report published on July 18 in the open-access journal PLoSGenetics describes a new approach to fighting cancer.Researchers have located a new type of ultrasensitive genes that seemto control the way cancer expresses itself (cancer-associatedphenotypes).

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Most Adults Don't Realize Activity Lowers Colon Cancer Risk
http://www.medicalnewstoday.com/articles/115430.php
Many experts now consider colon cancer a largely preventable disease, but a new study finds that primary care doctors might not always inform patients about one important step they can take to reduce their risk: becoming more physically active.

----------------------------------------------
** LUNG CANCER News **

BioNumerik Pharmaceuticals Observes Evidence Of A Survival Increase In Lung Cancer Patients Participating In Tavocept(TM) Clinical Trial
http://www.medicalnewstoday.com/articles/115415.php
BioNumerik Pharmaceuticals, Inc. ("BioNumerik") announced that patients with adenocarcinoma (the most frequently occurring form of lung cancer) participating in a Phase II clinical trial of Tavocept(TM) showed a survival increase of approximately 198 days (6.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Cancer Guide Blog

Thursday, July 31, 2008

Medical News Today News Alert

Wednesday, July 30, 2008

Medical News Today News Alert

Tuesday, July 29, 2008

Medical News Today News Alert

Monday, July 28, 2008

Medical News Today News Alert

Sunday, July 27, 2008

Medical News Today News Alert

Saturday, July 26, 2008

Medical News Today News Alert

Friday, July 25, 2008

Medical News Today News Alert

Thursday, July 24, 2008

Medical News Today News Alert

Wednesday, July 23, 2008

Medical News Today News Alert

Tuesday, July 22, 2008

Medical News Today News Alert

Monday, July 21, 2008

Medical News Today News Alert

Sunday, July 20, 2008

Medical News Today News Alert

Saturday, July 19, 2008

Medical News Today News Alert

Friday, July 18, 2008

Medical News Today News Alert

Partner Sites

Blog Archive

Health Information

About Me